Press release
Neurodegenerative Disease Market Expected to Reach $60.52 Billion by 2030 Growing at a 4.3% CAGR
Neurodegenerative Disease Market
According to the latest research by InsightAce Analytic, the global Neurodegenerative Disease market will be valued at US$ 41.79 Billion in 2021. It is expected to reach US$ 60.52 Billion by 2030, with a CAGR of 4.3% during a forecast period of 2022-2030.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1097
Neurodegenerative diseases continue to have a significant negative impact on both the mental and physical well-being of individuals, as well as on global healthcare expenditures. These disorders encompass a range of conditions that damage neurons in the brain, with Alzheimer's disease being the most prevalent neurological condition. In 2019, the United States alone recorded an estimated 5.8 million cases of Alzheimer's dementia. Other neurodegenerative disorders include Huntington's disease, spinal muscular atrophy, multiple system atrophy, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, among others.
The market for neurodegenerative diseases involves the sale of medications for these conditions, as well as related services. One of the primary drivers of growth in the neurodegenerative disease market is the increasing incidence of such conditions, largely due to the aging population. Neurodegenerative disorders are terminal diseases that primarily affect neurons in the brain, causing progressive degeneration or death of nerve cells. As the prevalence of these diseases continues to rise globally, the demand for treatments is also expanding. The growing elderly population is contributing significantly to the increase in neurological disorders. However, the market for treating these diseases faces substantial challenges, including high failure rates in clinical trials and research and development (R&D). Despite ongoing investments in R&D by numerous companies to develop treatment options for neurodegenerative diseases, few therapies have received regulatory approval to date.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
North America is expected to play a significant role in the growth of the Neurodegenerative Disease market. The expansion of the market in this region is driven by factors such as increased demand for medications, high healthcare costs, rising investments in research and development (R&D), and favorable health reimbursement policies. Additionally, the Asia Pacific market for neurodegenerative diseases is projected to experience considerable growth due to the aging population, a high prevalence of neurological disorders, and the growing demand for treatments for conditions such as Parkinson's and Alzheimer's disease, particularly in countries like China and Japan.
Major market players operating in the Neurodegenerative Disease market include
Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline and Other Key Players
Recent collaborations and agreements in the market:
• In March 2019, Novartis said that Mayzent had been approved by the FDA (siponimod). It is regarded as the first approved therapy for those with secondary progressive multiple sclerosis (SPMS). It is intended for patients who are 15 years of age and older.
• In January 2018, AVONEX, TYSABRI, and TECFIDERA began to be jointly promoted by Biogen Japan Ltd. and Eisai Co., Ltd. Biogen Japan produces them as a multiple sclerosis treatment. They will provide details on how these medications are used in hospitals.
Market Segments
Global Neurodegenerative Disease Market, by Drug Class, 2022-2030 (Value US$ Mn)
• NMDA
• SSRIs
• Dopamine Inhibitors
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1097
Global Neurodegenerative Disease Market, by Application, 2022-2030 (Value US$ Mn)
• Parkinson's Disease
• Huntington Disease
• Amyotrophic Lateral Sclerosis
• Alzheimer's Disease
Global Neurodegenerative Disease Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Neurodegenerative Disease market
To receive an industry overview and future trends of the Neurodegenerative Disease market
To analyze the Neurodegenerative Disease market drivers and challenges
To get information on the Neurodegenerative Disease market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Neurodegenerative Disease market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurodegenerative Disease Market Expected to Reach $60.52 Billion by 2030 Growing at a 4.3% CAGR here
News-ID: 3911857 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
